| Literature DB >> 30127328 |
Ruo-Han Qi1, Yan Chen1, Zhi-Lai Guo1, Fen Zhang1, Zheng Fang1, Kai Huang2, Hai-Ning Yu3, Yi-Peng Wang4.
Abstract
Antimicrobial peptides (AMPs) are a group of gene-encoded small peptides that play pivotal roles in the host immune system of multicellular organisms. Cathelicidins are an important family of AMPs that exclusively exist in vertebrates. Many cathelicidins have been identified from mammals, birds, reptiles and fish. To date, however, cathelicidins from amphibians are poorly understood. In the present study, two novel cathelicidins (OL-CATH1 and 2) were identified and studied from the odorous frog Odorrana livida. Firstly, the cDNAs encoding the OL-CATHs (780 and 735 bp in length, respectively) were successfully cloned from a lung cDNA library constructed for the frog. Multi-sequence alignment was carried out to analyze differences between the precursors of the OL-CATHs and other representative cathelicidins. Mature peptide sequences of OL-CATH1 and 2 were predicted (33 amino acid residues) and their secondary structures were determined (OL-CATH1 showed a random-coil conformation and OL-CATH2 demonstrated a-helical conformation). Furthermore, OL-CATH1 and 2 were chemically synthesized and their in vitro functions were determined. Antimicrobial and bacterial killing kinetic analyses indicated that OL-CATH2 demonstrated relatively moderate and rapid antimicrobial potency and exhibited strong anti-inflammatory activity. At very low concentrations (10 μg/mL), OL-CATH2 significantly inhibited the lipopolysaccharide (LPS)-induced transcription and production of pro-inflammatory cytokines TNF-a, IL-1b and IL-6 in mouse peritoneal macrophages. In contrast, OL-CATH1 did not exhibit any detectable antimicrobial or anti-inflammatory activities. Overall, identification of these OL-CATHs from O. livida enriches our understanding of the functions of cathelicidins in the amphibian immune system. The potent antimicrobial and anti-inflammatory activities of OL-CATH2 highlight its potential as a novel candidate in anti-infective drug development.Entities:
Keywords: Anti-inflammatory activity; Antimicrobial activity; Antimicrobial peptides (AMPs); Cathelicidins; OL-CATHs; Odorrana livida
Mesh:
Substances:
Year: 2018 PMID: 30127328 PMCID: PMC6378563 DOI: 10.24272/j.issn.2095-8137.2018.062
Source DB: PubMed Journal: Zool Res ISSN: 2095-8137
Primers used for quantitative real-time PCR
| Name | Forward (5 | Reverse (3 |
|---|---|---|
| TNF-α | CGGTGCCTATGTCTCAGCCT | GAGGGTCTGGGCCATAGAAC |
| IL-1β | ATGGCAACTGTTCCTGAACTC | GCCCATACTTTAGGAAGACA |
| IL-6 | AGTTGCCTTCTTGGGACTGA | TCCACGATTTCCCAGAGAAC |
| GAPDH | GTGAAGGTCGGTGTGAACGGATT | GGAGATGATGACCCTTTTGGCTC |
Figure 1cDNA sequences encoding the OL-CATHs and predicted prepropeptide sequences
Figure 2Multi-sequence alignment of the OL-CATHs with other representative cathelicidins
Physical and chemical parameters of OL-CATH1 and OL-CATH2
| Peptide | Grand average of hydropathicity | Number of amino acids ( | Net charge | Theoretical pI | Molecular weight |
|---|---|---|---|---|---|
| OL-CATH1 | −0.582 | 33 | 5+ | 9.89 | 3 788.4 |
| OL-CATH2 | −0.291 | 33 | 8+ | 10.41 | 3 673.4 |
Figure 3Secondary structure prediction of the OL-CATHs.
Physical and chemical parameters of OL-CATH1 and OL-CATH2
| Microorganisms | MIC (µg/mL) | ||
|---|---|---|---|
| OL-CATH1 | OL-CATH2 | Ampicillin | |
| >200 | 37.5 (10.21 µmol/L) | 4.69 (12.62 µmol/L) | |
| >200 | 9.38 (2.55 µmol/L) | 18.75 (50.48 µmol/L) | |
| >200 | 9.38 (2.55 µmol/L) | 9.38 (25.24 µmol/L) | |
| >200 | 37.5 (10.21 µmol/L) | >200 | |
| >200 | 75 (20.42 µmol/L) | 9.38 (25.24 µmol/L) | |
| >200 | >200 | 75 (201.9 µmol/L) | |
| >200 | >200 | 37.5 (100.9 µmol/L) | |
| >200 | >200 | >200 | |
MIC: Minimal inhibitory concentration. These concentrations represent mean values of three independent experiments performed in duplicates.
Killing kinetics of OL-CATH2 against Helicobacter pylori 11637
| Time (min) | Colony forming units (×10 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 0 | 10 | 20 | 30 | 45 | 60 | 90 | 120 | 180 | |
| OL-CATH2 | 55 | 54.7 | 39 | 13.7 | 0 | 0 | 0 | 0 | 0 |
| Ampicillin | 58.3 | 56.3 | 70 | 64.3 | 60 | 39.3 | 16.7 | 0 | 0 |
| Control | 58.7 | 64 | 58.3 | 58.3 | 67.7 | 68.7 | 65.3 | 62.7 | 69.3 |
Helicobacter pylori 11637 was mixed with samples at concentration of 5×MIC for 0, 10, 20, 30, 45, 60, 90, 120 and 160 mins. The results represent mean values of three independent experiments performed in duplicates.
Figure 4Anti-inflammatory activity of the OL-CATHs.